NASDAQ · INGN

Inogen Inc

Closing price · Nov 13, 2026 $5.69

Latest quarter · ended Sep 30, 2026

Sales slipped and cash got weaker

descriptionFiled Nov 9, 2026
Revenue growthShrinking
−2.4%
Quarter ended Dec 31, 2024: +5.5% sales vs. a year beforeQuarter ended Mar 31, 2025: +5.5% sales vs. a year beforeQuarter ended Jun 30, 2025: +4.0% sales vs. a year beforeQuarter ended Sep 30, 2025: −11.0% sales vs. a year beforeQuarter ended Dec 31, 2025: +52.3% sales vs. a year beforeQuarter ended Mar 31, 2026: +3.4% sales vs. a year beforeQuarter ended Jun 30, 2026: +3.0% sales vs. a year beforeQuarter ended Sep 30, 2026: −2.4% sales vs. a year before
Dec '24Sep '26
$77.2M vs. $79.1M a year ago
Gross marginWorse
44.1%
Quarter ended Dec 31, 2024: 45.3% gross marginQuarter ended Mar 31, 2025: 44.2% gross marginQuarter ended Jun 30, 2025: 44.8% gross marginQuarter ended Sep 30, 2025: 45.7% gross marginQuarter ended Dec 31, 2025: 42.7% gross marginQuarter ended Mar 31, 2026: 44.5% gross marginQuarter ended Jun 30, 2026: 45.5% gross marginQuarter ended Sep 30, 2026: 44.1% gross margin
Dec '24Sep '26
vs. 45.7% a year ago
Cash from operationsWorse
−$4.47M
Quarter ended Dec 31, 2024: −$3.02M cash from operationsQuarter ended Mar 31, 2025: −$16.8M cash from operationsQuarter ended Jun 30, 2025: $4.35M cash from operationsQuarter ended Sep 30, 2025: $2.17M cash from operationsQuarter ended Dec 31, 2025: −$943K cash from operationsQuarter ended Mar 31, 2026: −$6.68M cash from operationsQuarter ended Jun 30, 2026: $2.95M cash from operationsQuarter ended Sep 30, 2026: −$4.47M cash from operations
Dec '24Sep '26
−306% from $2.17M a year ago
Share countBuying back
−4.2%
Quarter ended Dec 31, 2024: 26.53M sharesQuarter ended Mar 31, 2025: 26.89M sharesQuarter ended Jun 30, 2025: 27.04M sharesQuarter ended Sep 30, 2025: 27.15M sharesQuarter ended Dec 31, 2025: 27.23M sharesQuarter ended Mar 31, 2026: 27.07M sharesQuarter ended Jun 30, 2026: 26.54M sharesQuarter ended Sep 30, 2026: 26M shares
Dec '24Sep '26
26M shares vs. 27.15M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 −50
  • account_balance
    0 funds bought, 3 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

130 funds report owning INGN, up from 126

Holdings as of Jun 30, 2026
New20
Added58
Held27
Trimmed25
Sold out16

Last quarter

Who bought and who sold

Apr–Jun 2026

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

No open-market buys or sales by officers or directors in the last 12 months. Hidden: 15 stock grants, 9 tax withholdings, 9 option exercises, 2 planned 10b5-1 sales. Press All filings to see them.

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOption exercise · Dec 1 · 31,566 shShares withheld for tax · Dec 1 · $90KOption exercise · Dec 1 · 28,334 shShares withheld for tax · Dec 1 · $96KStock grant · Mar 1 · $5.33KOption exercise · Mar 1 · 42,007 shShares withheld for tax · Mar 1 · $160KOption exercise · Mar 1 · 59,533 sh · 4 peopleShares withheld for tax · Mar 1 · $190K · 4 peopleStock grant · Mar 1 · $18.3K · 3 peopleOption exercise · Mar 1 · 58,346 shStock grant · Mar 1 · $4.18KShares withheld for tax · Mar 1 · $272KPlanned sale (10b5-1) · May 29 · $70.3KStock grant · Jun 5 · 196,567 sh · 7 peoplePlanned sale (10b5-1) · Jul 1 · $72.2KShares withheld for tax · Sep 1 · $46.2KOption exercise · Sep 1 · 18,136 shStock grant · Sep 1 · $16K · 2 peopleStock grant · Sep 1 · $8K
CEOCFOOther officersDirectorsJunJulAugSepOctNovStock grant · Jun 5 · 196,567 sh · 7 peoplePlanned sale (10b5-1) · Jul 1 · $72.2KShares withheld for tax · Sep 1 · $46.2KOption exercise · Sep 1 · 18,136 shStock grant · Sep 1 · $16K · 2 peopleStock grant · Sep 1 · $8K

Last 6 months. A wider screen shows 12.

Showing 0 real trades. Hidden: 15 stock grants, 9 tax withholdings, 9 option exercises, 2 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in INGN

As of Jun 30, 2026
FundOwnsValueChange
BlackRock, Inc.6.7%$11.3M+6%
Armistice Capital, LLC4.2%$7.07M−9%
Acadian Asset Management LLC4.2%$7.07M+1%
Vanguard Capital Management LLC4.0%$6.7MSame
Ameriprise Financial Inc3.8%$6.34M+14%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast